Evidence map›Paper›PMID 42389528›Full record

ArticleFrontiers in immunology2026

Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report.

Yanling Yuan, Wanming He, Lihua Tong, Yu Yang, Wen Yang

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yanling YuanDepartment of Oncology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, Guangdong, China.
Wanming HeDepartment of Oncology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, Guangdong, China.
Lihua TongDepartment of Oncology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, Guangdong, China.
Yu Yang *Department of Radiation Oncology, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, Guangdong, China.
Wen Yang *Department of Oncology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: FIGO stage IVA cervical cancer is frequently associated with extensive pelvic organ invasion and high treatment complexity. In selected patients with severe hemorrhage, renal dysfunction, or poor baseline condition, delivery of standard therapy may be clinically challenging. Case Presentation: We report a patient with FIGO stage IVA cervical squamous cell carcinoma presenting with massive vaginal bleeding, severe anemia, and renal dysfunction caused by extensive invasion of the rectum, bladder, distal ureter, and lower vagina. Emergent hemostatic radiotherapy achieved rapid bleeding control and clinical stabilization. Subsequently, an individualized conversion-oriented multimodal strategy integrating radiotherapy, targeted therapy, immunotherapy, and later consolidation chemotherapy was adopted with surgery as the intended endpoint. During treatment, serial image-guided radiotherapy (IGRT) monitoring prompted repeat CT simulation, target volume recontouring, and adaptive replanning according to tumor regression, enabling progressive reduction of irradiated target volumes while limiting unnecessary radiation exposure to adjacent pelvic organs. Marked tumor regression was achieved, followed by definitive radical surgery and pathologic complete response without recurrence during follow-up. Conclusion: This case suggests that, in highly selected patients with FIGO stage IVA cervical cancer, an individualized conversion-oriented multidisciplinary strategy incorporating IGRT-based monitoring and adaptive replanning may facilitate subsequent radical surgery and durable disease control. However, further clinical validation is required.

Indexed as

Carcinoma, Squamous CellUterine Cervical NeoplasmsCombined Modality TherapyFemaleHumansMiddle AgedNeoplasm StagingRadiotherapy, Image-GuidedTreatment Outcomeimage-guided radiotherapyimmune checkpoint inhibitorsimmunotherapyoperativerectovaginal fistulasurgical proceduresuterine cervical neoplasms

Identifiers

PMID42389528
PMCPMC13318737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.